{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:10:51Z","timestamp":1788865851997,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijantimicag.2026.107901","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:37:37Z","timestamp":1783093057000},"page":"107901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-6211","authenticated-orcid":false,"given":"Huifang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-2649","authenticated-orcid":false,"given":"Ruilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107901_bib0001","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0002","doi-asserted-by":"crossref","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0003","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-019-05819-3","article-title":"Epidemiology of intra-abdominal infection and sepsis in critically ill patients: \"AbSeS\", a multinational observational cohort study and ESICM Trials Group Project","volume":"45","author":"Blot","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-7922-9-37","article-title":"Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study","volume":"9","author":"Sartelli","year":"2014","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2015.12.019","article-title":"Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China","volume":"47","author":"Ouyang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2026.107901_bib0006","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0007","first-page":"1","article-title":"SSoCMA: Chinese Guidelines for diagnosis and treatment of abdominal infection (2019 edition)","volume":"40","year":"2020","journal-title":"Chin J Pract Surg"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The Surgical Infection Society Revised Guidelines on the management of intra-abdominal Infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jointm.2023.12.007","article-title":"Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: a narrative review","volume":"4","author":"Roger","year":"2024","journal-title":"J Intensive Med"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0010","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/jcpt.13342","article-title":"Good abdominal drainage fluid penetration and pharmacokinetics analysis of vancomycin for severe acute pancreatitis: a case report","volume":"46","author":"Wang","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0011","first-page":"4","article-title":"Research on vancomycin treatment for liver-transplantation and pharmacokinetics","volume":"10","author":"Qin Tang","year":"2002","journal-title":"Jiangsu Yao Xue Yu Lin Chuang Yan Jiu"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0012","series-title":"APGaPPA. Johns Hopkins ABX Guide: Diagnosis and Treatment of Infectious Diseases (Chinese version)","author":"Bartlett","year":"2012"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0013","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0014","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0015","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/AAC.42.10.2739","article-title":"In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis","volume":"42","author":"Lowdin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"Summary of recommendation statements","volume":"2","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0017","first-page":"377","article-title":"2020 CHINET China bacterial drug resistance surveillance","volume":"21","author":"Hu","year":"2021","journal-title":"Chin J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0018","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40265-021-01534-w","article-title":"Abdominal sepsis Study Group on behalf of the Trials Group of the European Society of Intensive Care M. Antimicrobial lessons from a large observational cohort on intra-abdominal infections in Intensive Care units","volume":"81","author":"Vogelaers","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","article-title":"The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0021","doi-asserted-by":"crossref","first-page":"e01602","DOI":"10.1128\/AAC.01602-17","article-title":"Pharmacokinetic\/pharmacodynamic determinants of Vancomycin efficacy in enterococcal bacteremia","volume":"62","author":"Jumah","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0022","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jiac.2023.07.010","article-title":"Association between ratio of area under the concentration-time curve to minimum inhibitory concentration of vancomycin and clinical outcomes in Enterococcus faecium bacteremia","volume":"29","author":"Komatsu","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0023","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/antibiotics11121748","article-title":"When and how to use MIC in clinical practice?","volume":"11","author":"Magreault","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107901_bib0024","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cmi.2020.03.008","article-title":"How to design a study to evaluate therapeutic drug monitoring in infectious diseases?","volume":"26","author":"Martson","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2026.107901_bib0025","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/519470","article-title":"Limitations of vancomycin in the management of resistant staphylococcal infections","volume":"45","author":"Kollef","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:47:45Z","timestamp":1788864465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0924857926001883"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107901","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107901"}}